PS Ratio
N/A
8 min ago
Summary
- CATX price to sales ratio is not available.
Performance
CATX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CATX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +0.6% | +0.6% | - |
| 1 m1 month | - | -6.9% | -6.9% | - |
| 3 m3 months | - | -70.6% | -70.6% | - |
| 6 m6 months | - | -70.9% | -70.8% | - |
| ytdytd | - | +6.9% | +6.9% | - |
| 1 y1 year | - | -62.0% | -48.1% | - |
| 5 y5 years | - | -62.4% | +276.9% | - |
CATX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | ||||
| 3 y | 3-year | 60.16 | 2.90 | ||
| 5 y | 5-year | 60.16 | 2.83 | ||
| alltime | all time | 243.13 | 0.58 |
Perspective Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2022 | 3.57(-31.1%) |
| 2021 | 5.18(+30.8%) |
| 2020 | 3.96(-20.6%) |
| 2019 | 4.99(+64.1%) |
| 2018 | 3.04(-25.5%) |
| 2017 | 4.08(-43.4%) |
| 2016 | 7.21(-31.0%) |
| 2015 | 10.45(-45.3%) |
| 2014 | 19.12(+360.7%) |
| Date | Value |
|---|---|
| 2013 | 4.15(-28.3%) |
| 2012 | 5.79(+52.8%) |
| 2011 | 3.79(-33.6%) |
| 2010 | 5.71(+48.7%) |
| 2009 | 3.84(+433.3%) |
| 2008 | 0.72(-89.3%) |
| 2007 | 6.71(-68.6%) |
| 2006 | 21.37(-84.6%) |
| 2005 | 139.19 |
FAQ
- What is the all time high PS ratio for Perspective Therapeutics?
What is the all time high PS ratio for Perspective Therapeutics?
Perspective Therapeutics all-time high price to sales ratio is 243.13